Washington University Institute of Clinical and Translational Sciences (KL2)

这是来自圣彼得堡华盛顿大学的CTSA申请。 Louis(Wu)建立在卓越的生物医学研究、研究培训、 和病人护理。吴是CTSA(GCRC目前处于其资助的第45个年头，K12多学科临床研究生涯的基础)的4项临床研究和培训补助金的获得者 发展奖、K30临床研究课程奖、T32博士前临床研究 培训补助金)。目前应用的另一个关键因素是吴的新的Bied 21战略 在基因组科学、生物成像和生物成像领域建立多学科合作研究的倡议 临床调查。所有这些元素将与吴的现有资源结合在一起，形成 一个变革性的新的临床科学研究所(ICS)的基础。ICS通过实施 本申请中详细描述的15个程序功能将在概念上和 从操作上重塑和重振临床和转化性研究以及临床研究培训 在吴，现在和未来都是如此。 ICS将在吴领导的转型的核心是开发一个 与其他学术、医疗和科学机构的伙伴关系达到前所未有的水平 补充我们在实验室和临床研究以及研究培训方面的核心专业知识。我们的合作伙伴 包括圣路易斯BJC Healthcare，一个集成的学术和社区医疗保健提供系统 大学公共卫生、医学和护理学院以及医疗伦理和健康中心 法律和医疗保健成果，巴恩斯犹太护理学院和联合健康，华盛顿大学 密苏里州圣路易斯和南伊利诺伊州爱德华斯维尔护理学院和圣路易斯学院 药房以及圣路易斯地区的主要生物医学和制药公司。这个 吴的资源与我们合作伙伴的互补资源相结合，创造了 一个杰出的环境，在这个环境中，基本的实验室发现可以被做出，然后转化为 临床研究方案，并最终通过以下途径促进临床实践和患者护理 广泛的社区互动和商业伙伴关系。为了确保ICS的成功，吴说 已经做出了大量的空间和财政支持承诺。巴恩斯-犹太人和圣路易斯 儿童医院，我们的学术医院合作伙伴和BJC Healthcare，我们的附属医疗系统 都对ICS的临床研究活动做出了实质性的承诺。这些附加内容 资源与现有的高质量临床和翻译科学项目相结合，确保 华盛顿大学将成为机构临床与翻译专业的杰出获得者 科学奖。

This CTSA application from Washington University in St. Louis (WU) is built on a long institutional history of outstanding biomedical research, research training, and patient care. WU is the recipient of the 4 clinical research and training grants that form the basis of the CTSA (GCRC currently in its 45th year of funding, K12 multidisciplinary clinical research career development award, K30 clinical research curriculum award, and T32 predoctoral clinical research training grant). Another critical element in the present application is WU's new Biomed 21 strategic initiative to build multidisciplinary, collaborative research in genome sciences, biological imaging, and clinical investigation. All these elements will be conjoined along with existing resources at WU to form the foundation of a transformational new Institute of Clinical Sciences (ICS). The ICS by implementing the 15 Program Functions that are described in detail in this application will conceptually and operationally reinvent and reinvigorate clinical and translational research and clinical research training at WU, for now and in the future. Central to the transformation that will be lead at WU by the ICS is the development of an unprecedented level of partnership with other academic, healthcare and scientific institutions that complement our core expertise in laboratory and clinical research and research training. Our partners include BJC Healthcare, an integrated academic and community health care delivery system, St. Louis University Schools of Public Health, Medicine and Nursing and Centers for Healthcare Ethics, Health Law and Healthcare Outcomes, Barnes Jewish School of Nursing and Allied Health, University of Missouri St. Louis and Southern Illinois at Edwardsville Schools of Nursing and St. Louis College of Pharmacy as well as key biomedical and pharmaceutical companies in the St. Louis area. The combination of the resources at WU coupled with the complementary resources of our partners creates an outstanding environment in which basic laboratory discoveries can be made and then translated into clinical research protocols and ultimately into advances in clinical practice and patient care through extensive community interactions and commercial partnerships. To ensure the success of the ICS, WU has made substantial commitments of space and financial support. Barnes-Jewish and St. Louis Children's Hospitals our academic hospital partners and BJC Healthcare our affiliated health system have all made substantial commitments to the clinical research activities of the ICS. These additional resources coupled with the existing high quality programs in clinical and translational science ensure that Washington University with be an outstanding recipient of an Institutional Clinical and Translational Science Award.